Edgewise Therapeutics (EWTX) Stock Chart & Stock Price History → Guard Against the Coming Financial Upheaval (From Porter & Company) (Ad) Free EWTX Stock Alerts $17.48 -0.85 (-4.64%) (As of 05/13/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Edgewise Therapeutics Stock Price Performance5 Day Performance-12.60%1 Month Performance+6.78%3 Month Performance-2.56%6 Month Performance+168.51%Year-To-Date Performance+59.78%1 Year Performance+88.57% Receive EWTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Edgewise Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyAmerica’s worst nightmare?What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. EWTX Stock Chart for Tuesday, May, 14, 2024 EWTX Chart by TradingView Edgewise Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$18.33$17.48-4.64%$18.57$17.41637,355 shs$1.63 billion05/10/2024$20.00$18.33-8.35%$19.99$17.961.14 million shs$1.71 billion05/09/2024$20.89$20.00-4.26%$20.83$19.391.03 million shs$1.86 billion05/08/2024$21.23$20.89-1.60%$21.60$20.37686,921 shs$1.95 billion05/07/2024$20.34$21.23+4.38%$21.57$20.02777,039 shs$1.98 billion05/06/2024$19.52$20.34+4.20%$20.44$18.98587,300 shs$1.89 billion Get the Latest News and Ratings for EWTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edgewise Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$19.29$19.52+1.19%$20.12$19.44545,133 shs$1.82 billion05/02/2024$19.01$19.29+1.47%$19.55$18.531.16 million shs$1.80 billion05/01/2024$17.94$19.01+5.96%$20.90$17.37984,906 shs$1.77 billion04/30/2024$17.05$17.94+5.22%$18.29$16.70536,801 shs$1.67 billion04/29/2024$16.17$17.05+5.44%$17.61$16.27607,174 shs$1.59 billion04/26/2024$15.94$16.17+1.44%$16.93$15.99676,052 shs$1.51 billion04/25/2024$16.11$15.94-1.06%$15.97$15.08607,514 shs$1.48 billion04/24/2024$15.65$16.11+2.94%$16.33$15.60526,410 shs$1.50 billion04/23/2024$15.08$15.65+3.78%$15.90$15.10557,752 shs$1.46 billion04/22/2024$15.23$15.08-0.98%$15.95$14.92378,814 shs$1.40 billion04/19/2024$15.45$15.23-1.42%$15.76$14.90543,656 shs$1.42 billion04/18/2024$15.65$15.45-1.28%$16.05$15.27531,462 shs$1.44 billion04/17/2024$16.63$15.65-5.89%$16.93$15.62681,629 shs$1.46 billion04/16/2024$16.48$16.63+0.91%$16.88$15.90561,136 shs$1.55 billion04/15/2024$16.37$16.48+0.67%$16.75$16.13403,480 shs$1.53 billion04/12/2024$16.49$16.37-0.73%$16.48$15.81411,582 shs$1.52 billion04/11/2024$15.93$16.49+3.52%$16.63$15.56318,135 shs$1.54 billion04/10/2024$16.19$15.93-1.61%$16.06$15.55562,610 shs$1.48 billion04/09/2024$16.88$16.19-4.09%$16.91$15.73481,397 shs$1.51 billion04/08/2024$16.96$16.88-0.47%$17.43$16.67678,937 shs$1.57 billion04/05/2024$16.52$16.96+2.66%$17.75$16.10525,814 shs$1.58 billion04/04/2024$18.50$16.52-10.70%$19.21$16.331.10 million shs$1.54 billion04/03/2024$17.67$18.50+4.70%$18.63$17.29495,310 shs$1.72 billion04/02/2024$18.02$17.67-1.94%$17.84$17.36392,218 shs$1.65 billion04/01/2024$18.24$18.02-1.21%$18.38$17.55375,983 shs$1.68 billion03/29/2024$18.24$18.24$18.27$17.56479,083 shs$1.70 billion03/28/2024$17.96$18.24+1.56%$18.27$17.56479,083 shs$1.70 billion03/27/2024$17.14$17.96+4.78%$18.11$17.26414,835 shs$1.67 billion03/26/2024$16.00$17.14+7.13%$17.55$16.11683,164 shs$1.60 billion03/25/2024$16.25$16.00-1.54%$16.36$15.71345,461 shs$1.49 billion03/22/2024$16.89$16.25-3.79%$17.07$16.24524,924 shs$1.51 billion03/21/2024$16.77$16.89+0.72%$17.09$16.22765,549 shs$1.57 billion03/20/2024$16.19$16.77+3.58%$16.84$15.63426,238 shs$1.56 billion03/19/2024$15.53$16.19+4.25%$16.53$15.47706,128 shs$1.51 billionAmerica’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now.03/18/2024$16.92$15.53-8.22%$16.82$15.431.15 million shs$1.45 billion03/15/2024$17.07$16.92-0.88%$18.03$16.874.67 million shs$1.58 billion03/14/2024$17.41$17.07-1.95%$17.43$16.68555,721 shs$1.59 billion03/13/2024$17.72$17.41-1.75%$18.37$17.37451,104 shs$1.62 billion03/12/2024$16.75$17.72+5.79%$18.00$16.541.52 million shs$1.65 billion03/11/2024$17.16$16.75-2.39%$17.09$16.71455,244 shs$1.56 billion03/08/2024$17.74$17.16-3.27%$17.90$16.79891,636 shs$1.60 billion03/07/2024$17.00$17.74+4.35%$17.99$17.42625,974 shs$1.65 billion03/06/2024$16.97$17.00+0.18%$17.29$16.82658,817 shs$1.58 billion03/05/2024$17.00$16.97-0.18%$17.60$16.75692,347 shs$1.58 billion03/04/2024$16.69$17.00+1.86%$17.07$16.50797,376 shs$1.58 billion03/01/2024$16.33$16.69+2.20%$17.17$16.17735,318 shs$1.06 billion02/29/2024$16.65$16.33-1.92%$17.17$16.03864,212 shs$1.04 billion02/28/2024$16.85$16.65-1.19%$17.09$16.11782,268 shs$1.06 billion02/27/2024$17.04$16.85-1.12%$17.70$16.82968,432 shs$1.07 billion02/26/2024$17.28$17.04-1.39%$17.67$16.82494,427 shs$1.08 billion02/23/2024$17.37$17.28-0.52%$18.38$17.27466,786 shs$1.10 billion02/22/2024$17.50$17.37-0.74%$18.44$17.11722,122 shs$1.10 billion02/21/2024$17.57$17.50-0.40%$17.88$17.41584,805 shs$1.11 billion02/20/2024$17.37$17.57+1.15%$18.25$17.041.07 million shs$1.11 billion02/19/2024$17.37$17.37$18.42$17.20806,600 shs$1.10 billion02/16/2024$18.32$17.37-5.19%$18.42$17.20806,655 shs$1.10 billion02/15/2024$17.94$18.32+2.12%$18.63$17.671.51 million shs$1.16 billion02/14/2024$18.91$17.94-5.13%$19.56$17.90517,441 shs$1.14 billion02/13/2024$18.95$18.91-0.21%$18.95$17.64794,295 shs$1.20 billion Related Companies: Syndax Pharmaceuticals Stock Chart Amneal Pharmaceuticals Stock Chart NewAmsterdam Pharma Stock Chart Galapagos Stock Chart Amphastar Pharmaceuticals Stock Chart Deciphera Pharmaceuticals Stock Chart Agios Pharmaceuticals Stock Chart Structure Therapeutics Stock Chart Keros Therapeutics Stock Chart Rocket Pharmaceuticals Stock Chart Receive EWTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Edgewise Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EWTX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.